<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Hormonal Disorder]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/therapeutic-areas/hormonal-disorder</link>
    <description><![CDATA[Hormonal Disorder]]></description>
    <pubDate>Fri, 10 Apr 2026 06:00:35 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Hypothyroidism (Hormonal Disorders) - Drugs in Development, 2021]]></title>
      <link>https://www.leadingmarketresearch.com/hypothyroidism-hormonal-disorders-drugs-in-development-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism - Drugs In Development, 2021, provides an overview of the Hypothyroidism (Hormonal Disorders) pipeline landscape.Hypothyroidism (underactive thyroid) is a condition in which thyroid gland doesn&#039;t produce enough of certain important hormones. Signs and symptom include fatigue, constipation, dry skin, puffy face, muscle weakness, muscle aches, tenderness and stiffness, pain and stiffness. Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease.<br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Hypothyroidism - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Hypothyroidism (Hormonal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological ac...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-221640"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 12 Oct 2021 15:07:55 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Growth Hormone Deficiency - Global Clinical Trials Review, H2, 2021]]></title>
      <link>https://www.leadingmarketresearch.com/growth-hormone-deficiency-global-clinical-trials-review-h2-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Growth Hormone Deficiency - Global Clinical Trials Review, H2, 2021&quot; provides an overview of Growth Hormone Deficiency Clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter str...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-220385"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Sep 2021 16:07:52 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Lipid Disorders Global Clinical Trials Review, H2, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/lipid-disorders-global-clinical-trials-review-h2-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Lipid Disorders Global Clinical Trials Review, H2, 2017&quot; provides an overview of Lipid Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Lipid Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200359"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 18 Jan 2018 13:06:38 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/hormone-deficiency-disorders-global-clinical-trials-review-h2-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Hormone Deficiency Disorders Global Clinical Trials Review, H2, 2017&quot; provides an overview of Hormone Deficiency Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Deficiency Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200394"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 18 Jan 2018 13:06:38 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/growth-hormone-deficiency-global-clinical-trials-review-h2-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2017&quot; provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200397"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 18 Jan 2018 13:06:38 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023]]></title>
      <link>https://www.leadingmarketresearch.com/growth-hormone-deficiency-ghd-market-insights-epidemiology-and-marke</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency (GHD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Growth Hormone Deficiency (GHD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Growth Hormone Deficiency (GHD) till 2023. 

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Growth Hormone Deficiency (GHD) market. 
• Identifying patient populations in the global “Growth Hormone Deficiency (GHD) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Growth Hormone Deficiency (GHD) therapeu...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-183825"><span class="price">$4,950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 24 Aug 2016 13:19:26 +0000</pubDate>
    </item>
  </channel>
</rss>
